Functional and pathway enrichment analysis revealed that multiple signaling molecules including MAPK and PI3K-Akt pathways could be involved in the pharmacological actions of FMNT against ischemic diseases (Figure 2). This evidence concerns the gene AKT1 and ischemic disease.